143 related articles for article (PubMed ID: 3536983)
1. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
Stockigt JR; Scoggins BA
J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
[TBL] [Abstract][Full Text] [Related]
2. Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.
Woodland E; Tunny TJ; Hamlet SM; Gordon RD
Clin Exp Pharmacol Physiol; 1985; 12(3):245-8. PubMed ID: 2992855
[TBL] [Abstract][Full Text] [Related]
3. The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Higgins JR; Kramer NJ
J Lab Clin Med; 1976 Aug; 88(2):261-70. PubMed ID: 182890
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?
Connell JM; Kenyon CJ; Corrie JE; Fraser R; Watt R; Lever AF
Hypertension; 1986 Aug; 8(8):669-76. PubMed ID: 3015796
[TBL] [Abstract][Full Text] [Related]
5. A case of glucocorticoid-suppressible hyperaldosteronism with aldosterone producing adenoma.
Kato S; Haji M; Yanase T; Nawata H; Kato K; Ibayashi H
Endocrinol Jpn; 1988 Apr; 35(2):311-20. PubMed ID: 3208706
[TBL] [Abstract][Full Text] [Related]
6. Regulation of aldosterone secretion in primary aldosteronism.
Vetter H; Vetter W
Horm Metab Res; 1975 Sep; 7(5):418-24. PubMed ID: 1183923
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid hypertension in childhood.
New MI; Levine LS
Mayo Clin Proc; 1977 May; 52(5):323-8. PubMed ID: 323586
[TBL] [Abstract][Full Text] [Related]
8. Evidence for an unidentified ACTH-induced steroid hormone causing hypertension.
New MI; Peterson RE; Saenger P; Levine LS
J Clin Endocrinol Metab; 1976 Dec; 43(6):1283-93. PubMed ID: 187612
[TBL] [Abstract][Full Text] [Related]
9. Normotensive glucocorticoid-suppressible hyperaldosteronism in adult.
Maeda T; Ashie T; Kikuiri K; Takakura M; Hikita N; Nakagawa H; Shimamoto K
Endocrinol Jpn; 1989 Dec; 36(6):817-25. PubMed ID: 2633910
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension.
Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA
J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571
[TBL] [Abstract][Full Text] [Related]
11. A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.
Fallo F; Sonino N; Armanini D; Luzzi T; Pedini F; Pasini C; Mantero F
Clin Endocrinol (Oxf); 1985 Jun; 22(6):777-85. PubMed ID: 2990765
[TBL] [Abstract][Full Text] [Related]
12. Circadian rhythm and effect of posture on plasma aldosterone concentration in primary aldosteronism.
Schambelan M; Brust NL; Chang BC; Slater KL; Biglieri EG
J Clin Endocrinol Metab; 1976 Jul; 43(1):115-31. PubMed ID: 947931
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-suppressible aldosteronism: a disorder of the adrenal transitional zone.
Gomez-Sanchez CE; Gill JR; Ganguly A; Gordon RD
J Clin Endocrinol Metab; 1988 Sep; 67(3):444-8. PubMed ID: 2842358
[TBL] [Abstract][Full Text] [Related]
14. Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.
Yamakita N; Yasuda K; Noritake N; Mercado-Asis LB; Murase H; Mune T; Morita H; Miura K
Acta Endocrinol (Copenh); 1989 Sep; 121(3):334-44. PubMed ID: 2552725
[TBL] [Abstract][Full Text] [Related]
15. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
Skrabal F; Mauser R
Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
[TBL] [Abstract][Full Text] [Related]
16. [Primary hyperaldosteronism suppressed after glucocorticoid administration].
Brzezińska A; Słowińska-Srzednicka J; Wieteska-Klimczak A; Wyszyńska T; Januszewicz P
Endokrynol Pol; 1992; 43(3):330-5. PubMed ID: 1345573
[TBL] [Abstract][Full Text] [Related]
17. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
Wisgerhof M; Carpenter PC; Brown RD
J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
[TBL] [Abstract][Full Text] [Related]
18. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
[TBL] [Abstract][Full Text] [Related]
19. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
Norby L; Mark AL; Kaloyanides GJ
Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]